Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01240356 · ClinicalTrials.gov registry record · Phase 1
CLOTBUST Hands-Free: A Phase I/II Pilot Safety Trial
A Phase 1 study, sponsored by The University of Texas Health Science Center, Houston.
- Completed
- Registry status
- Phase 1
- Development phase
- 35
- Enrollment target
NCT01240356 is a Phase 1 study that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 35 participants.
The verdict
NCT01240356, a Phase 1 study, has completed, sponsored by The University of Texas Health Science Center, Houston.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 35 participants
- Enrollment target
Study Summary
The purpose of CLOTBUST-HF is to determine the safety of a novel, external Hands-Free transcranial Doppler (TCD) ultrasound system in healthy volunteers and ischemic stroke patients. If found to be safe, the widespread use of operator-independent, ultrasound-enhanced thrombolysis will allow the planning for a large Phase III efficacy trial.
Interventions
- DEVICE 2-MHz transcranial Doppler ultrasound
- DEVICE 2-MHz transcranial Doppler ultrasound insonation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2008-12 |
| Est. Completion | 2013-10 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01240356
The ClinicalTrials.gov registry entry for NCT01240356 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which 2-MHz transcranial Doppler ultrasound is the first listed.
NCT01240356 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01240356 about?
NCT01240356 is a clinical study titled "CLOTBUST Hands-Free: A Phase I/II Pilot Safety Trial". The purpose of CLOTBUST-HF is to determine the safety of a novel, external Hands-Free transcranial Doppler (TCD) ultrasound system in healthy volunteers and ischemic stroke patients. If found to be safe, the widespread use of operator-independent, ultrasound-enhanced thrombolysis will allow the plan...
What is the current status of trial NCT01240356?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 35 participants. The study started on 2008-12. Estimated completion is 2013-10.
What interventions are being tested in trial NCT01240356?
The interventions under investigation include: 2-MHz transcranial Doppler ultrasound (DEVICE), 2-MHz transcranial Doppler ultrasound insonation (DEVICE).
Who is sponsoring clinical trial NCT01240356?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.